Adicet Bio, Inc. ( ACET) - Key Metrics
ACET Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.99 | -$1.84 | -$1.86 |
| 2026Q1 | $0 | -$1.88 | -$2 | -$2 |
| 2025Q4 | $0 | -$4.43 | -$3.03 | -$3.03 |
| 2025Q3 | $0 | -$4.72 | -$3.92 | -$3.96 |
| 2025Q2 | $0 | -$5.48 | -$4.68 | -$4.69 |
ACET Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.09 |
| 2026Q1 | 0% | -0.91 |
| 2025Q4 | 0% | -0.72 |
| 2025Q3 | 0% | -0.70 |
| 2025Q2 | 0% | -0.45 |
ACET
Price: $9.11
52 week price:
Payout Ratio Range:
Earnings Per Share: -10.46 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400300
Ebitda: 12.8 millionMarket Capitalization: 77.3 million